EXPERIENCE LIFE WITHOUT PAIN™
EXPERIENCE LIFE WITHOUT PAIN™
Here at Kentuckiana Integrative Medicine of Jeffersonville, our physicians and medical practitioners offer a medical breakthrough treatment known as Stem Cell Therapy to the Louisville, KY area.
We are one of the most experienced stem cell team in the Kentuckiana area. Our treatment approaches are evidence based on sound research which demonstrates clear benefits in variety of clinical situations. The treatment is individualized and tailored specifically based on each patient’s unique clinical condition.
We have performed more stem cell harvesting from via Bone Marrow Aspiration, Adipose “fatty tissue” Aspiration of Mesenchymal Stem cells and Stem cell procedures and other forms of regenerative medicine than the majority of clinics in the USA. Our clinicians are Board Certified with advanced training and skill. Conditions that have been effectively treated or improved with mesenchymal stem cell-MSC therapy include but are not limited to the list below. NOTE: We DO NOT necessarily treat ALL listed conditions; however, extensive compelling research and clinical experience suggests benefit in all listed areas.
Mesenchymal Stem Cell Therapy (MSC) is one of the newest and most advanced therapies in Regenerative and Integrative Medicine for a variety of medical problems that are not easily treated with traditional conventional allopathic medical approaches. There is an abundance of clinical experience by numerous physicians, patients and researchers proving consistently that mesenchymal stem cell-MSC therapy can be extremely helpful in a wide variety of medical conditions that are difficult to treat, such as stem cell therapy for knees, shoulder injuries and hip conditions. Clearly not all conditions and or patients will be helped with Mesenchymal Stem Cell Therapies. However, the reported scientific evidence of effective results from patients, physicians and researchers in a variety of medical conditions is impressive. No other medical therapies in recent medical history have offered as much hope and concrete results of patient improvement.
At Kentuckiana Integrative Medicine, we offer a variety of mesenchymal stem cell-MSC therapies. While not all of the above conditions are treated at Kentuckiana Integrative Medicine, we are leaders in the field of Regenerative Medicine through the use of BMA -Bone Marrow derived mesenchymal stem cells- MSCs as well as Wharton’ Jelly Umbilical Cord Tissues-MSCs.
Very few others have performed as many treatments/procedures as we have. We tailor the therapy based upon your specific condition, needs and preferences. While we are experts at harvesting mesenchymal stem cells-MSCs from a patient’s body, we prefer to use umbilical cord tissue products from healthy newborn babies because these tissues have much larger quantities of more powerful, non-rejectable “immune privileged” newborn mesenchymal stem cells-MSC and growth factors. Immune Privileged means that these newborn umbilical MSCs will not be rejected by the patient receiving them.
Unlike other stem cells that are derived from fat tissue or bone marrow, Kentuckiana Integrative Medicine offers mostly injections using stem cells from umbilical cord tissue of live healthy births. The use of umbilical cord mesenchymal stem cells is easier for patients and some sources believe are more effective. However, which MSCs- Mesenchymal Stem Cells are more effective remains a frequently debated topic among researchers and clinicians providing patient care.
For patients who prefer the use of their own stem cells, we are happy to accommodate your preference and harvest from BONE MARROW with our nearly painless or PAINLESS proprietary techniques. The live newborn stem cells cannot be rejected and are by far more powerful and abundant than the stem cells collected from a “tired” 35 to 85 year old person’s bone marrow or fat. The newborn mesenchymal stem cells are NOT yet tired since they just arrived!!!! In complex cases, we frequently use ultrasound guidance or X-ray fluoroscopic guidance for precise delivery of the mesenchymal stem cells to the injured tissue.
Stem cells are undifferentiated cells that can transform into specialized cells such as heart, neurons, liver, lung, skin and so on and can also divide to produce more stem cells. In a child or young adult, these stem cells are in large supply, acting as a built-in repair system. They are often summoned to the site of damage or inflammation to repair and restore normal function.
But as we age, our supply of stem cells begins to diminish as much as 100- to 10,000-fold in different tissues and organs. In addition, stem cells undergo genetic mutations, which reduce their quality and effectiveness at renovating and repairing your body.
Stem cells are cells that have the ability to divide and develop into many different cell types in the body during early life and growth. Stem cells may also help repair the body by dividing to replenish cells that are damaged by disease, injury, or normal wear and by recruitment of your own bodies “repairmen” stem cells.
When a stem cell divides, each new cell has the potential either to remain a stem cell or to become any other type of cell with a more specialized function, such as a nerve cell, a skin cell, or a red blood cell. According to Dr. Neil Riordan a stem cell expert, MSCs – Mesenchymal Stem Cells are also Master Medicinal Signaling Cells that release messenger compounds which stimulate other cells to begin the healing and regeneration process. They also have immune-modulation properties which allow them to reduce inflammation and or pain which is a part of most every chronic disease.
The revolutionary PX50, Amniotic, Placenta, Umbilical, Adpipose and Bone Marrow derived MSCs and or growth factors can help people suffering with a multitude of conditions.
Mesenchymal Stem Cell Therapy is extremely safe and effective. The injections/therapies have been used more than 60,000 times in the United States with no reported adverse side effects and with a 100% safety record in Europe with more than 100,000 patients treated. The FDA has approved only cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications. The FDA has NOT approved any other stem cell-based or regenerative products for use, despite an overwhelming amount of clinical evidence of benefit. The FDA has approved some skin grafting mesenchymal stem cell products used for non-healing wounds.
All of our products are processed from donated human tissue from full term deliveries in accordance with FDA guidelines and DO NOT contain any fetal or embryonic tissue. All products are regulated as a human cell, tissue, or cellular or tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act. While the FDA has not approved use of Mesenchymal Stem Cells, currently physicians and patients are permitted the use Mesenchymal Stem Cells if they both conclude that the benefits outweigh the risks.
There are 5 components that are delivered by the Umbilical Cord Stem Cell Therapy injections – Mesenchymal Stem Cells – MSCs, Scaffold Components, Growth Factors, MMP Inhibitors, and Anti-Inflammatories.
Stem cells are found in people of all ages. They remain dormant in your body until they receive signals that the body has suffered an injury and then they will locate the injured body area(s).
Acting as master cells, stem cells have the ability to form into any type of cell in our body and are responsible along with many other cells and growth factors to heal injured ligaments, tendons, joints, tissues, organs and bones etc.
The Mesenchymal Stem Cell Therapy procedures are injections typically requiring 15-60 minutes depending on the complexity of the situation. Often they are done under Ultrasound Guidance. The mesenchymal stem cell therapy injection is performed in our office and provides improved function and pain relief without the risks of surgery, general anesthesia, hospital stays or prolonged recovery. The recovery time after our therapies varies from none to a few days depending on the therapy received. Healing begins soon after the therapy, but improvement of symptoms may take 1-3 months again depending on the medical condition.
Below are clinical scenarios and our very own patients that demonstrate the incredible research and clinical implications for stem cell therapies on patients. The future is very promising today when it comes to stem cell therapy.
Our patient, Jim of Louisville, KY, discusses how stem cell therapy, PRP therapy and prolozone helped him avoid Total Knee Replacement Surgery.
Jim Dearing of Louisville, Ky., one of the first men in the world to receive heart stem cells, might have helped start a medical revolution that could lead to a cure for heart failure. Three years after getting the experimental stem cell procedure, following two heart attacks and heart failure, Jim Dearing’s heart is working normally. The difference is clear and dramatic — and it’s lasting, according to findings now being made public for the first time.
Dearing first showed “completely normal heart function” on an echocardiogram done in 2011, says Roberto Bolli, MD, who is leading the stem cell trial at the University of Louisville. Those results have not been published before. That was still true in July 2012, when Dearing again showed normal heart function on another echocardiogram. Based on those tests, Dr. Bolli says, “Anyone who looks at his heart now would not imagine that this patient was in heart failure, that he had a heart attack, that he was in the hospital, that he had surgery, and everything else.”
It’s not just Dearing who has benefited. His friend, Mike Jones, who had even more severe heart damage, also got the stem cell procedure in 2009. Since then, scarred regions of his heart have shrunk. His heart now appears leaner and stronger than it was before. “What’s striking and exciting is that we’re seeing what appears to be a long-lasting improvement in function,” Bolli says. If larger studies confirm the findings,”potentially, we have a cure for heart failure because we have something that for the first time can actually regenerate dead tissue.
Over the last decade, the number of publications per year on stem cell-related research has increased 40x. The stem cell market is expected to reach $170 billion by 2020. Rising R&D initiatives to develop therapeutic options for chronic diseases and growing demand for a regenerative treatment option are the most significant drivers of this budding industry.
Here are some areas of frequent interest.
Stem Cell Revolution – We are at the cusp of a stem cell revolution. Understanding and harnessing these unique cells may unlock breakthroughs in longevity and therapeutic solutions to all kinds of chronic diseases and regenerative opportunities.
As humans, we’ve just come to accept the notion that we are going to die. However, the keys to our longevity and health may lie in our source code.
In the next two decades, stem cells are going to change medicine forever, extend life, and potentially save lives. We truly live during the most exciting time ever in human history.
Heart Disease: https://www.ncbi.nlm.nih.gov/pubmed/23117550
Parkinson’s Disease: http://www.translationalres.com/article/S1931-5244(09)00220-5/abstract